1
Contralateral breast radiation doses in breast cancer patients treated with helical tomotherapy, Medical Dosimetry, 48(1), 2023
Ezgi Oymak 1, Prof. Dr. Erkan Topkan, Recep Bozca 2, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
2
The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy, Eur J Nucl Med Mol Imaging, 50(0), 2023
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Ezgi Oymak, Prof. Dr. Mehmet Reyhan |
3
The impact of the apparent diffusion coefficient for the early prediction of the treatment response after definitive radiotherapy in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 184(0), 2023
Prof. Dr. Hüseyin Cem Önal, Erbay G, Oymak E, Doç. Dr. Ozan Cem Güler |
4
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study, Journal of Pseudo-Differential Operators and Applications, 31(3), 2023
Doç. Dr. Ozan Cem Güler, Oymak E, Yazici G, Akagunduz Oo, Cetinayak O, Erpolat P, Aksoy A, Duzova M, Yildirim Ba, Kurt M, Canyilmaz E, Yavas G, Akyurek S, Oksuz Dc, Saglam Ek, Celik Ok, Ozyar E, Cengiz M, Prof. Dr. Hüseyin Cem Önal |
5
Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(5), 2023
Yavas G, Doç. Dr. Ozan Cem Güler, Gultekin M, Oymak E, Yuce Sari S, Yildiz F, Prof. Dr. Hüseyin Cem Önal |
6
Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients, PROSTATE, 83(12), 2023
Doç. Dr. Ozan Cem Güler |
7
Prostat Kanseri Radyoterapisinde PSMA-PET Güvenilirliği ve Kısıtlılığı, nükleer tıp seminerleri, 1(0), 2023
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
8
The Effect of Bladder Volume on Three-dimensional Vaginal Cuff Brachytherapy Planning, Turk Onkoloji Dergisi-Turkish Journal of Oncology, 0(0), 2023
Duru Birgi S, Doç. Dr. Ozan Cem Güler, Babayigit Y, Arslan Y, Akyürek S. |
9
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. In regard to Rajwa et al, European Urology Oncology, 2023(0), 2023
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler |
10
Comparison of helical and TomoDirect techniques with simultaneous integrated boost in early breast cancer patients, Reports of Practical Oncology and Radiotherapy, 4(0), 2023
Prof. Dr. Hüseyin Cem Önal, Bozca R, Oymak E, Doç. Dr. Ozan Cem Güler |
11
The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy, RADIOTHERAPY AND ONCOLOGY, 173(0), 2022
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Doç. Dr. Ozan Cem Güler, Oymak E |
12
Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes, the journal of obstetrics and gynecological researh, 48(7), 2022
Yuce Sari S, Doç. Dr. Ozan Cem Güler, Oymak E, Gultekin M, Yigit E, Kahvecioglu A, Yuce K, Celik H, Usubutun A, Bolat F, Prof. Dr. Hüseyin Cem Önal, Yildiz F. |
13
Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 33(1), 2022
Oymak E, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
14
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis. In regard to De Virgilio et al, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(9), 2022
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
15
Longer treatment time and lower radiation doses?an alternative for Graves? ophthalmopathy treatment, STRAHLENTHERAPIE UND ONKOLOGIE, 198(7), 2022
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler |
16
Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients with Pathologic Negative Nodes after Neoadjuvant Chemotherapy. In regard to Schlafstein et al., Clinical Breast Cancer, 22(3), 2022
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
17
Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. In Regard to Harmon et al., INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 112(2), 2022
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
18
Re: Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease., CLINICAL ONCOLOGY, 34(4), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E., Doç. Dr. Ozan Cem Güler |
19
Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma, Journal of Pseudo-Differential Operators and Applications, 107(2), 2022
Doç. Dr. Ozan Cem Güler, Oymak E, Hurmuz P, Yavas G, Tilki B., Yavas C., Ozyigit G., Prof. Dr. Hüseyin Cem Önal |
20
Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54, European Urology Oncology, 5(4), 2022
Doç. Dr. Ozan Cem Güler, İsci O., Prof. Dr. Hüseyin Cem Önal |
21
Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial, EUROPEAN JOURNAL OF CANCER, 167(0), 2022
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
22
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 199(5), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E, Doç. Dr. Ozan Cem Güler, Tilki B, Yavas G, Hurmuz P, Yavas C, Öğr.Gör. Ebru Seyhun |
23
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma, Clinical & Translational Oncology, 24(8), 2022
Prof. Dr. Hüseyin Cem Önal, Hurmuz P, Doç. Dr. Ozan Cem Güler, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G. |
24
Re: Francolini et al.: Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis., CLINICAL ONCOLOGY, 34(1), 2022
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
25
Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy., Journal of Pseudo-Differential Operators and Applications, 198(3), 2022
Oymak E, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
26
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study, STRAHLENTHERAPIE UND ONKOLOGIE, 198(10), 2022
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Hurmuz P, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G. |
27
The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 42(6), 2022
Prof. Dr. Hüseyin Cem Önal, Gultekin M, Yavas G, Oymak E, Yuce Sari S, Doç. Dr. Ozan Cem Güler, Yigit E, Yildiz F |
28
There is no doubt about the winner of the lion?rabbit fight, PROSTATE, 82(12), 2022
Prof. Dr. Hüseyin Cem Önal, Oymak E., Doç. Dr. Ozan Cem Güler |
29
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002, European Urology Oncology, 5(4), 2022
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
30
Dosimetric Comparison of Volumetric Arc Therapy Methods for Stereotactic Body Radiotherapy in Liver Metastasis, Turkish journal of oncology, 37(4), 2022
Oymak E, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
31
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerIn Regard to Deek et al. , INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(5), 2021
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Oymak E |
32
NRG oncology updated international consensus atlas on pelvic lymph node volumes for intact and postoperative prostate cancer: In Regard to Hall et al, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 110(2), 2021
Prof. Dr. Hüseyin Cem Önal, Oymak E., Doç. Dr. Ozan Cem Güler |
33
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 81(9), 2021
Prof. Dr. Hüseyin Cem Önal, Kose F, Ozyigit G, Aksoy S, Oymak E, Muallaoglu S, Doç. Dr. Ozan Cem Güler, Tilki B, Hurmuz P, Akyol F |
34
Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 11(0), 2021
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Doç. Dr. Ozan Cem Güler, Tilki B, Hurmuz P, Akyol F |
35
Long-term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.: in regard to Lin et al. , CLINICAL ONCOLOGY, 33(0), 2021
Prof. Dr. Hüseyin Cem Önal, Oymak E., Doç. Dr. Ozan Cem Güler |
36
Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapy, Future Oncology, 17(25), 2021
Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yavas G, Doç. Dr. Ozan Cem Güler, Yigit E, Oymak E, Gultekin M, Yildiz F. |
37
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al., MEDICAL ONCOLOGY, 38(7), 2021
Prof. Dr. Hüseyin Cem Önal, Oymak E, Doç. Dr. Ozan Cem Güler |
38
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study, CLINICAL NUCLEAR MEDICINE, 46(6), 2021
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Akgun Z, Atalar B, İgdem S, Oymak E, Agaoglu F, Selek U, Doç. Dr. Ozan Cem Güler, Hurmuz P, Mustafayev Tz, Akyol F.: |
39
Prognostic factors of endometrial cancer in elderly patient group and their effects on survival., north clinical istanbul, 8(4), 2021
Alemdaroglu S, Durdag Gd, Baran Sy, Simsek Sy, Yetkinel S, Yaginc Da, Doç. Dr. Ozan Cem Güler, Celik H. |
40
The clinical outcomes of ovarian cancer in patients with brain metastasis, EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 42(5), 2021
Seda Yuksel Simsek1, Doç. Dr. Ozan Cem Güler, Gülşen Doğan Durdag1, Sezin Yüce Sari3, Melis Gultekin3, Ferah Yildiz3, Husnu Celik1, Gurcan Erbay4, Prof. Dr. Hüseyin Cem Önal |
41
Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients, PROSTATE, 108(3), 2021
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Oymak E, Doç. Dr. Ozan Cem Güler, Hurmuz P, Tilki B, Reyhan M, Tuncel M, Akyol F. |
42
Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy, ACTA ONCOLOGICA, 60(9), 2021
Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yavas G, Oymak E, Duru Birgi S, Yigit E, Doç. Dr. Ozan Cem Güler, Gultekin M, Akyurek S, Yildiz F |
43
Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 31(2), 2021
Gultekin M, Beduk Esen Cs, Balci B, Alanyali S, Akkus Yildirim B, Doç. Dr. Ozan Cem Güler, Yuce Sari S, Ergen Sa, Sahinler I, Alsan Cetin I, Prof. Dr. Hüseyin Cem Önal, Yildiz F, Ozsaran Z. |
44
The effect of androgen deprivation therapy on Ga-68-PSMA tracer uptake in non-metastatic prostate cancer patients, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 47(3), 2020
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar |
45
Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients, Radiologia Medica, 125(8), 2020
Prof. Dr. Hüseyin Cem Önal, Bozca R, Dolek Y, Doç. Dr. Ozan Cem Güler, Arslan G. |
46
Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension, Journal of BUON, 25(4), 2020
Fatih Kose 1, Songul Alemdaroglu, Huseyin Mertsoylu, Ali Ayberk Besen, Doç. Dr. Ozan Cem Güler, Seda Yuksel Simsek, Gurcan Erbay, Prof. Dr. Hüseyin Cem Önal, Husnu Celik |
47
Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30(6), 2020
Prof. Dr. Hüseyin Cem Önal, Gultekin M, Oymak E, Doç. Dr. Ozan Cem Güler, Yilmaz Mt, Sari Sy, Yildirim Ba, Yildiz F. |
48
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 151(0), 2020
Prof. Dr. Hüseyin Cem Önal, Gökhan Özyiğit, Doç. Dr. Ozan Cem Güler, Pervin Hürmüz, Doç. Dr. Neşe Torun, Murat Tuncer, Yemliha Dölek, Yağız Yedekçi, Ezgi Oymak, Burak Tilki, Fadil Akyol |
49
Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse, LEUKEMIA RESEARCH, 41(6), 2020
50. Kose F, Alemdaroglu S, Besen Aa, Doç. Dr. Ozan Cem Güler, Mertsoylu H, Prof. Dr. Hüseyin Cem Önal, Celik H. |
50
Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy, BREAST, 80(4), 2020
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Yildirim Ba |
51
Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002), STRAHLENTHERAPIE UND ONKOLOGIE, 196(11), 2020
Hurmuz P, Prof. Dr. Hüseyin Cem Önal, Ozyigit G, İgdem S, Atalar B, Sayan H, Akgun Z, Kurt M, Basak Ozkok H, Selek U, Oymak E, Tilki B, Doç. Dr. Ozan Cem Güler, Mustafayev Tz, Saricanbaz İ, Rzazade R, Fadil Akyol |
52
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, RADIOTHERAPY AND ONCOLOGY, 151(0), 2020
Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Doç. Dr. Ozan Cem Güler, Hurmuz P, Torun N, Tuncel M, Dolek Y, Yedekci Y, Oymak E, Tilki B, Akyol F. |
53
National, Observational, Multicentric Retrospective Study to Understand Treatment Patterns, Patient Journey and Characteristics with Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial, International Journal of Hematology and Oncology, 108(3), 2020
Prof. Dr. Hüseyin Cem Önal, Demiral An, Atalar B, Doç. Dr. Ozan Cem Güler, Yalman D, Dagoglu N, Hurmuz P, Erpolat P, Akyurek S, Karabulut Gul S, Berber T, Guler Oc, Umay C, Sert F, Karahacioglu E, Birgi Sd, Yaprak G, Kaytan Saglam E. |
54
Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation, Journal of Applied Clinical Medical Physics, 21(9), 2020
59. Haciislamoglu E, Gungor G, Aydin G, Canyilmaz E, Doç. Dr. Ozan Cem Güler, Zengin Ay, Yenice Km. |
55
Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy, ANNALS OF NUCLEAR MEDICINE, 34(0), 2020
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Neşe Torun, Ezgi Oymak, Doç. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar |
56
Definitive concurrent chemoradiotherapy outcomes in Stage IIIB nonsmall cell lung cancer patients younger than 45 years: A retrospective analysis of 145 patients, Journal of Cancer Research and Therapeutics, 16(4), 2020
Prof. Dr. Erkan Topkan, Doç. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir |
57
Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy, Journal of Oncology, 2020(0), 2020
Topkan E, Ozdemir Y, Kucuk A, Doç. Dr. Ozan Cem Güler, Sezer A, Besen Aa, Mertsoylu H, Senyurek S, Kilic Durankus N, Bolukbasi Y, Selek U, Pehlivan B. |
58
Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study, Journal of Oncology, 2020(0), 2020
Topkan E, Ozdemir Y, Doç. Dr. Ozan Cem Güler, Kucuk A, Besen Aa, Mertsoylu H, Sezen D, Akdemir Ey, Sezer A, Bolukbasi Y, Pehlivan B, Selek U. |
59
Concurrent versus sandwich treatment in adjuvant treatment in high risk operated gastric cancer: A single center experience, Journal of BUON, 25(5), 2020
Sezer A, Akkus B, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Sumbul At., Öğr.Gör. Mehmet Burak Önal |
60
Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 40(7), 2020
Prof. Dr. Hüseyin Cem Önal, Yuce Sari S, Yildirim Ba, Gultekin M, Doç. Dr. Ozan Cem Güler, Yildiz F |
61
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer, BREAST, 54(0), 2020
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Alper Fındıkcıoğlu, Doç. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan |
62
Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy, ANNALS OF NUCLEAR MEDICINE, 34(6), 2020
Prof. Dr. Hüseyin Cem Önal, Torun N, Oymak E, Doç. Dr. Ozan Cem Güler, Reyhan M, Yapar Af |
63
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients, CLINICAL NUCLEAR MEDICINE, 44(0), 2019
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Neşe Torun, Fadıl Akyol, Doç. Dr. Ozan Cem Güler, Pervin Hürmüz, Berna Akkuş Yıldırım, Meltem Çağlar, Prof. Dr. Mehmet Reyhan, Gökhan Özyiğit |
64
Local Control and Vertebral Compression Fractures Following Stereotactic Body Radiotherapy for Spine Metastases, Journal of Bone Oncology, 24(15), 2019
Doç. Dr. Yurday Özdemir, Doç. Dr. Neşe Torun, Doç. Dr. Ozan Cem Güler, Berna Akkuş, Ali Ayberk Beşen, Doç. Dr. Aylin Güneşli Yetişken, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
65
Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients, Medical Dosimetry, 44(4), 2019
Yıldırım Ba, Dolek Y, Doç. Dr. Ozan Cem Güler, Arslan G, Prof. Dr. Hüseyin Cem Önal |
66
Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide, INDIAN JOURNAL OF CANCER, 56(1), 2019
Doç. Dr. Ozan Cem Güler, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
67
Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019
Ozyigit G, Prof. Dr. Hüseyin Cem Önal, Igdem S, Arican Alicikus Z, Iribas A, Akin M, Yalman D, Cetin I, Aksu Mg, Atalar B, Dincbas F, Hurmuz P, Doç. Dr. Ozan Cem Güler, Aydin B, Sert F, Yildirim C1, Gorken Ib, Agaoglu Fy, Korcum Af, Yuce D, Ozkok S, Darendeliler E, Akyol F |
68
Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction, Clinical Breast Cancer, 19(5), 2019
Yuce Sari S, Doç. Dr. Ozan Cem Güler, Gultekin M, Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Ozyigit G, Yildiz F. |
69
Prognostic Value of Metabolic Response Measured by FDG-PET-CT in Patients with Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy, Current Medical Imaging Reviews, 33(3), 2019
Doç. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal |
70
A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma, Journal of Gynecologic Oncology, 30(3), 2019
Prof. Dr. Hüseyin Cem Önal, Sari Sy, Yildirim Ba, Yavas G, Gultekin M, Doç. Dr. Ozan Cem Güler, Akyurek S, Yildiz F: |
71
Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases, Journal of Bone Oncology, 15(0), 2019
Ozdemir Y, Torun N, Doç. Dr. Ozan Cem Güler, Yildirim Ba, Besen Aa, Yetisken Ag, Onal Hc, Topkan E. |
72
Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(1), 2019
Prof. Dr. Hüseyin Cem Önal, Akkus Yildirim B, Yuce Sari S, Yavas G, Gultekin M, Doç. Dr. Ozan Cem Güler, Yildiz F, Akyurek S.: |
73
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate, STRAHLENTHERAPIE UND ONKOLOGIE, 195(10), 2019
66. Yildirim Ba, Prof. Dr. Hüseyin Cem Önal, Kose F, Oymak E, Sedef Am, Besen Aa, Aksoy S, Doç. Dr. Ozan Cem Güler, Sumbul At, Muallaoglu S, Mertsoylu H, Ozyigit G. |
74
The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 39(5), 2019
Yıldırım Ba, Doç. Dr. Ozan Cem Güler, Prof. Dr. Fatih Köse, Prof. Dr. Hüseyin Cem Önal |
75
Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients, CLINICAL NUCLEAR MEDICINE, 44(9), 2019
Prof. Dr. Hüseyin Cem Önal, Torun N, Akyol F, Doç. Dr. Ozan Cem Güler, Hurmuz P, Akkus Yildirim B, Caglar M, Reyhan M, Ozyigit G.: |
76
Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery, IN VIVO, 33(6), 2019
Prof. Dr. Hüseyin Cem Önal, Efe E, Doç. Dr. Ozan Cem Güler, Yıldırım Ba |
77
Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 105(1), 2019
Gultekin M, Doç. Dr. Ozan Cem Güler, Guler Oc, Yuce Sari S, Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Celik H, Yuce K, Ayhan A, Arik Z, Kose F, Altundag O, Zoto Mustafayev T, Atalar B, Bolukbasi Y, Yildiz F. |
78
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate., Future Oncology, 37(7), 2019
Prof. Dr. Hüseyin Cem Önal, Sedef Am, Kose F, Oymak E, Doç. Dr. Ozan Cem Güler, Sumbul At, Aksoy S, Yıldırım Ba, Besen Aa, Muallaoglu S, Mertsoylu H, Ozyigit G. |
79
Prognostic values of ADCmean and SUVmax of the primary tumor in cervical cancer patients treated with definitive chemoradiotherapy., JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 0(0), 2019
56. Akkus Yildirim B, Prof. Dr. Hüseyin Cem Önal, Erbay G, Doç. Dr. Ozan Cem Güler, Karadeli E, Reyhan M, Koc Z.: |
80
Mide Kanserinde Definitif Radyoterapi. Üst Gastrointestinal Kanserlerde Radyoterapi. , Türkiye Klinikleri, 1(0), 2018
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
81
Radiotherapy in the management of classic Kaposi?xxs sarcoma: A single institution experience from Northeast Turkey, Dermatologic Therapy, 31(4), 2018
Kandaz M, Bahat Z, Doç. Dr. Ozan Cem Güler, Canyilmaz E, Melikoglu M, Yoney A. |
82
Outcomes of Treatment for Glioblastoma Multiforme in Adult Patients: A Single Institution Experience from the Eastern Black Sea Region of Turkey., International Journal of Hematology and Oncology, 0(0), 2018
Kandaz M, Bahat Z, Doç. Dr. Ozan Cem Güler, Canyılmaz E, Yazar U, Yoney A |
83
Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients, Journal of Oncology, 2018(0), 2018
Topkan E, Selek U, Ozdemir Y, Besen Aa, Doç. Dr. Ozan Cem Güler, Yildirim Ba, Mertsoylu H, Findikcioglu A, Ozyilkan O, Pehlivan B. : |
84
Incidence and Impact of Pretreatment Tumor Cavitation on Survival Outcomes of Stage III Squamous Cell Lung Cancer Patients Treated With Radical Concurrent Chemoradiation Therapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 101(5), 2018
58. Topkan E, Selek U, Ozdemir Y, Yildirim Ba, Doç. Dr. Ozan Cem Güler, Ciner F, Besen Aa, Findikcioglu A, Ozyilkan O: |
85
Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 39(6), 2018
Yıldırım Ba, Doç. Dr. Neşe Torun, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
86
Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem, ANNALS OF ONCOLOGY, 29(3), 2018
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Ozyar E |
87
Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer, LUNG CANCER, 121(0), 2018
57. Topkan E, Selek U, Ozdemir Y, Yildirim Ba, Doç. Dr. Ozan Cem Güler, Mertsoylu H, Hahn Sm. |
88
Responding to Veiga et al. 'Long term radiological features of radiation-induced lung damage', RADIOTHERAPY AND ONCOLOGY, 129(3), 2018
Oymak E, Yıldırım Ba, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
89
Whole brain radiotherapy plus conventional boost in Non-Small Cell Lung Cancer Patients with brain metastasis: a retrospective analysis of overall survival., Turkish Neurosurgery, 0(0), 2018
Kandaz M, Doç. Dr. Ozan Cem Güler, Yazar U, Cenyılmaz E, Yoney A |
90
Prognostic role of pretreatment level hemoglobin levels in patients with local advanced rectum cancer treated with preoperative chemotherapy, Cukurova Medical Journal, 43(3), 2018
Berna Akkuş Yıldırım1, Ahmet Taner Sümbül2, Doç. Dr. Ozan Cem Güler, Ali Murat Sedef4, Cem Önal1, Erkan Topkan |
91
The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 28(8), 2018
Prof. Dr. Hüseyin Cem Önal, Yıldırım Ba., Doç. Dr. Ozan Cem Güler, Mertsoylu H |
92
Effect of adjuvant extended temozolamide treatment in survival of patients with glioblastoma multiforme, Cukurova Medical Journal, 43(3), 2018
Yıldırım Ba, Su?Mbu?L At, Doç. Dr. Ozan Cem Güler, Sedef Am, Önal C, Topkan E: |
93
The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients, Clinical & Translational Oncology, 20(4), 2018
Doç. Dr. Ozan Cem Güler, Benedikt Engels, Prof. Dr. Hüseyin Cem Önal, Evaraert H, Van Den Begin R, Gevaert T, De Ridder M |
94
Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide, JOURNAL OF NEURO-ONCOLOGY, 139(2), 2018
60. Topkan E, Selek U, Ozdemir Y, Yildirim Ba, Doç. Dr. Ozan Cem Güler, Ciner F, Mertsoylu H, Tufan K |
95
Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?, Oncology Research and Treatment, 40(9), 2017
Yuce Sari S, Doç. Dr. Ozan Cem Güler, Gultekin M, Prof. Dr. Hüseyin Cem Önal, Yildiz F. |
96
The role of delineation education programs for improving interobserver variability in target volume delineation in gastric cancer, BRITISH JOURNAL OF RADIOLOGY, 90(1073), 2017
Prof. Dr. Hüseyin Cem Önal, Cengiz M, Doç. Dr. Ozan Cem Güler, Dolek Y, Ozkok S |
97
Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 27(7), 2017
Doç. Dr. Ozan Cem Güler, Sezin Yüce Sarı, Sumerya Duru Birgi, Melis Bahadır, Ferah Yıldız, Prof. Dr. Hüseyin Cem Önal |
98
Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images, ACTA RADIOLOGICA, 58(4), 2017
Prof. Dr. Gürcan Erbay, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Elif Karadeli, Doç. Dr. Ozan Cem Güler, Arica S, Koc Z |
99
Prognostic Value of Pretreatment HER2 Status in Gastric Cancer Patients Treated with Postoperative Chemoradiotherapy, turkish journal of oncology, 0(0), 2017
Doç. Dr. Ozan Cem Güler, Kandaz M, Bahat Z, Canyılmaz E, Çakır E, Yoney A: |
100
Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis, molecular and clinical oncology, 7(1), 2017
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Yıldırım Ba |
101
Lokalize Prostat Kanserinde Radyoterapi, Türkiye Klinikleri, 0(0), 2017
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
102
Larinks Kanserinde Radyoterapi., Türkiye Klinikleri, 0(0), 2017
Doç. Dr. Ozan Cem Güler, Canyılmaz E |
103
The effect of chemoradiotherapy at gastric cancer on pancreatic enzymes and pancreas volume., INTERNATIONAL JOURNAL OF HEMATOLOGY, 0(0), 2017
Kandaz M., Doç. Dr. Ozan Cem Güler, Yoney A. |
104
Malignant Mesenchymal Tumor of the Prostate: A Case Report., turkish journal of oncology, 0(0), 2017
Kandaz M, Doç. Dr. Ozan Cem Güler, Karaman E, Mungan S, Yoney A: |
105
Pretreatment metabolic tumor volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy., JOURNAL OF MARINE RESEARCH, 0(0), 2017
Doç. Dr. Ozan Cem Güler, Doç. Dr. Neşe Torun, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal |
106
Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 26(6), 2016
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Yıldırım Ba |
107
Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature, WIENER KLINISCHE WOCHENSCHRIFT, 128(7), 2016
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Müh. Güngör Arslan |
108
Impact of Peritumoral Edema on Overall Survival in Glioblastoma Multiforme, turkish journal of oncology, 0(0), 2016
Kandaz M, Doç. Dr. Ozan Cem Güler, Yazar U, Ucuncu Sy, Yoney A: |
109
Adjuvant radiotherapy in management of trichilemmal carcinoma of left nasal alae with positive surgical margins A case report, case reports in clinical pathology, 3(4), 2016
Topkan E, Doç. Dr. Ozan Cem Güler, Bal N, Ozdemir Y: |
110
High Prognostic Nutritional Index Relates with Enhanced Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy, Wulfenia, 0(0), 2016
Yıldırım Ba, Özdemir Y, Doç. Dr. Ozan Cem Güler, Prof. Dr. Erkan Topkan |
111
Prognostic value of metabolic response measured by F-18-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy, NUCLEAR MEDICINE COMMUNICATIONS, 37(12), 2016
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Neşe Torun, Doç. Dr. Ozan Cem Güler, Yıldırım Ba |
112
Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 14(2), 2016
Doç. Dr. Ozan Cem Güler, Prof. Dr. Nebil Bal, Prof. Dr. Hüseyin Cem Önal |
113
Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy, JOURNAL OF MAGNETIC RESONANCE IMAGING, 44(4), 2016
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Doç. Dr. Ozan Cem Güler |
114
Endometrial Adenosarcoma: Case Report, annals of clinical case reports, 1(1170), 2016
Kandaz M, Karaman E, Doç. Dr. Ozan Cem Güler, Mungan S, Yoney A. : |
115
Prognostic value of F-18-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy, GYNECOLOGIC ONCOLOGY, 137(1), 2015
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Prof. Dr. Mehmet Reyhan, Prof. Dr. Ali Fuat Yapar |
116
The impact of air pockets around the vaginal cylinder on vaginal vault brachytherapy., Journal of Cancer Research and Therapeutics, 0(0), 2015
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Dolek Y |
117
Correlation of Clinical Risk Factors with Diffusion-Weighted Magnetic Resonance Images in Prostate Cancer Patients Treated with Definitive Radiotherapy, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 25(2), 2015
Erbay, Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Prof. Dr. Elif Karadeli, Koc Z |
118
Safety and Palliative Efficacy of Single-Dose 8-Gy Reirradiation for Painful Local Failure in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Radical Chemoradiation Therapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(4), 2015
Prof. Dr. Erkan Topkan, Yıldırım Ba, Doç. Dr. Ozan Cem Güler, Parlak C, Pehlivan B, Selek U |
119
Metastatik Evre ve Lokal Nükslerde Radyoterapi, Türkiye Klinikleri, 0(0), 2015
Doç. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir, Prof. Dr. Hüseyin Cem Önal |
120
Hepatoselüer Karsinomda Radyoterapi, türkiye Klinikleri, 0(0), 2014
Doç. Dr. Ozan Cem Güler |
121
Prostate Mucinous Carcinoma Treated With Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the Literature, Clinical Genitourinary Cancer, 12(2), 2014
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Gürcan Erbay, Prof. Dr. Nebil Bal |
122
Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41(7), 2014
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Doç. Dr. Ozan Cem Güler, Prof. Dr. Ali Fuat Yapar |
123
Uterine Perforation During 3-Dimensional Image-Guided Brachytherapy in Patients With Cervical Cancer Baskent University Experience, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 24(2), 2014
Prof. Dr. Hüseyin Cem Önal, Doç. Dr. Ozan Cem Güler, Dolek Y, Prof. Dr. Gürcan Erbay |
124
Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy, BRITISH JOURNAL OF RADIOLOGY, 87(1034), 2014
Prof. Dr. Hüseyin Cem Önal, Sonmez S, Erbay G, Doç. Dr. Ozan Cem Güler, Arslan G |
125
Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 88(4), 2014
Parlak C, Mertsoylu H, Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
126
Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer, Journal of Contemporary Brachytherapy, 6(4), 2014
Doç. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Acibuci İ |
127
Outcomes of aggressive concurrent radiochemotherapy in highly selected septuagenarians with stage IIIB non-small cell lung carcinoma: Retrospective analysis of 89 patients, LUNG CANCER, 81(2), 2013
54. Topkan E, Parlak C, Topuk S, Doç. Dr. Ozan Cem Güler, Selek U.: |
128
PROGNOSTIC VALUE OF PRETREATMENT FDG UPTAKE IN CERVICAL CANCER PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 23(8), 2013
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Mehmet Reyhan, Parlak C, Doç. Dr. Ozan Cem Güler, Oymak E |
BAŞKENT ÜNİVERSİTESİ